Navigation Links
Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
Date:12/7/2012

HERTFORDSHIRE, United Kingdom, Dec. 7, 2012 /PRNewswire-iReach/ -- Artemis Diagnostics, a developer of innovative imaging technologies for cancer surgery, announced today that the company has been awarded two Smart grants from the Technology Strategy Board, the UK's innovation agency. The two grants, totaling more than £120,000 (US$ 193,000), provide funding for the company to develop its imaging devices for clinical trials and to undertake market research in the US and UK.

Dr David Tuch, CEO of Artemis Diagnostics, commented, "We are pleased the Technology Strategy Board has selected Artemis Diagnostics to receive funding for our product development and market research. The Smart scheme is highly competitive and these awards provide further affirmation of the company's technology and the tremendous need for improved tools to detect cancer during surgery. We believe our molecular imaging technology will provide a significant advance in precision-guided surgery. We look forward to working with our surgeon collaborators to bring our technology into clinical trials."

About the Technology Strategy Board
The Technology Strategy Board is the UK's innovation agency.  Its goal is to accelerate economic growth by stimulating and supporting business-led innovation.  Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

About the Smart scheme
Managed by the Technology Strategy Board, the Smart scheme offers funding to small and medium-sized enterprises (SMEs) to engage in R&D projects in the strategically important areas of science, engineering and technology, from which successful new products, processes and services could emerge. http://www.innovateuk.org/deliveringinnovation/smart.ashx

About Artemis Diagnostics
Artemis Diagnostics is a medical device start-up seeking to improve health outcomes for cancer patients through image-guided surgery. The company's molecular imaging technology, based on Cerenkov luminescence imaging, has the potential to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue. For more information contact info@artemisdiagnostics.com or visit www.artemisdiagnostics.com.

Media Contact: Artemis Diagnostics Artemis Diagnostics, +44 7725 832 539, info@artemisdiagnostics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Artemis Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
2. High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe, Finds Frost & Sullivan
3. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
4. Cynosure to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
5. Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
6. Roche Diagnostics Breaks Ground on New Learning and Development Center
7. Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
8. Quest Diagnostics Confirms Investor Day on November 16
9. Johnson & Johnson Postpones Medical Devices & Diagnostics Review
10. Johnson & Johnson to Host Medical Devices & Diagnostics Review
11. Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... 26, 2017 , ... Journal of Oral Implantology – Tooth loss ... overall dental health, including complications with speech, eating, and overcompensation of mouth due to ... lost teeth. As the number of tooth replacements increase, it is imperative to design ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, president and CEO ... Enterprising Women magazine as one of its 2017 Enterprising Women of the Year, ... have demonstrated that they have fast-growth businesses, mentor or actively support other women ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you ... to get nutrients from SUPERFOODS! , RawTrition is taking nutrients to the ... level because the body recognizes its raw form (unlike the synthetically made options that ...
(Date:4/26/2017)... FL (PRWEB) , ... April 26, 2017 , ... ... and human performance, is proud to announce that it has received 510(k) clearance ... technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary ...
(Date:4/25/2017)... ... 25, 2017 , ... Coalition Duchenne, a ... muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on positive ... trial in Duchenne announced today. , Coalition Duchenne funded studies carried out ...
Breaking Medicine News(10 mins):